tegaserod: Clinical Trials

14 completed, 8 terminated, 1 no longer available, 1 unknown. 14 Phase 3, 6 Phase 4, 3 Phase 2, 2 Not applicable.

By phase and status

Phase	Trials	Status
Phase 3	14	Completed 10, Terminated 4
Phase 4	6	Completed 3, Terminated 2, Withdrawn 1
Phase 2	3	Terminated 2, Completed 1
Not applicable	2	Terminated 1, Unknown 1

Follow tegaserod: new trials by email Literature Review of tegaserod trials Research Report on tegaserod

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. Tegaserod - Opioid-induced Constipation	Phase 3	Terminated	Novartis	11	2007-02-01	2012-04-20
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis Tegaserod - Gastroparesis, Diabetes	Phase 4	Terminated	Novartis	40	2007-01-01	2012-05-04
Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain. Tegaserod - Opioid-induced Constipation	Phase 3	Terminated	Novartis	360	2006-11-01	2012-05-01
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients Tegaserod - Chronic Constipation	Phase 4	Terminated	Novartis	60	2006-07-01	2016-03-04
Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain Tegaserod - Constipation	Phase 2 / Phase 3	Terminated	Novartis	670	2006-07-01	2012-04-20
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation Tegaserod and Polyethylene Glycol 3350 - Constipation	Phase 4	Completed	Novartis	52	2005-05-01	2016-03-03
The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn. Tegaserod - Dyspepsia	Phase 3	Completed	Novartis	60	2005-04-01	2008-02-01
The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. Tegaserod - Heartburn, Dyspepsia	Phase 3	Completed	Novartis	24	2005-04-01	2007-10-10
An Evaluation of the Efficacy and Safety of Tegaserod 6 mg Bid Given Orally to Chinese Patients With Chronic Constipation Tegaserod - Constipation	Phase 3	Completed	Novartis	600	2005-02-01	2008-02-01
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation tegaserod - Constipation, Chronic Disease	Not applicable	Terminated	Hospital Authority, Hong Kong	250	2004-12-01	2011-06-16
Study of Effect of Tegaserod on Small and Large Bowel Transit by Scintigraphic Method Tegaserod - Constipation	Not applicable	Unknown	Hospital Authority, Hong Kong	60	2004-11-01	2010-07-07
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS) Tegaserod - Constipation Predominant, Irritable Bowel Syndrome (IBS-C)	Phase 3	Terminated	Novartis Pharmaceuticals	20	2004-11-01	2012-04-20
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia Tegaserod - Dyspepsia	Phase 3	Completed	Novartis	359	2004-09-01	2008-02-01
Extension Study to Assess the Long-Term Safety of Tegaserod in Women With Symptoms of Dyspepsia Tegaserod - Dyspepsia	Phase 3	Completed	Novartis	423	2004-09-01	2008-02-01
Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy Tegaserod - Diabetic Gastropathy	Phase 2	Terminated	Novartis	120	2004-05-01	2012-04-20
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia Tegaserod - Dyspepsia	Phase 3	Completed	Novartis	1296	2004-05-01	2016-11-18
Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS Tegaserod - IBS-C and IBS With Mixed Bowel Habits	Phase 4	Completed	Novartis	664	2004-04-01	2008-01-28
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation Tegaserod - Chronic Constipation	Phase 4	Completed	Novartis	250	2004-04-01	2008-02-01
Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. Tegaserod - Chronic Constipation	Phase 3	Completed	Novartis	1026	2004-03-01	2008-02-01
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia Tegaserod - Dyspepsia	Phase 3	Completed	Novartis	1296	2004-01-01	2008-02-01

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Constipation (9)  ·  Dyspepsia (7)  ·  Gastroesophageal Reflux (3)  ·  Heartburn (3)  ·  Opioid-Induced Constipation (3)  ·  Diabetes Mellitus (2)  ·  Chronic Disease (1)  ·  Gastroparesis (1)  ·  Irritable Bowel Syndrome (1)  ·  Stomach Diseases (1)

Sponsors

Novartis (22)  ·  Hospital Authority, Hong Kong (2)  ·  Novartis Pharmaceuticals (1)

Countries

United States (16)  ·  China (3)  ·  Switzerland (3)  ·  Egypt (1)  ·  Singapore (1)  ·  Taiwan (1)  ·  Venezuela (1)

Top investigators

Ambrose CP Kwan, Dr (1)  ·  Annie OO Chan, Dr (1)  ·  Henry Parkman, MD (1)  ·  Michael Crowell, PhD (1)  ·  Nicholas Talley, MD (1)  ·  William Chey, MD (1)

Results publications

PMID 18561877, PMID 18616658